Author

Anja Ulmer

Universitätsklinikum TübingenORCID 0000-0001-8378-9518Unclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Signature Assays, Organisms & Methods

Click to filter · or open tag

Assay:bulk RNA-seq· 2 Approach:experimental assay· 2 Organism:human· 2 Research Focus:cell type annotation· 1 Research Focus:cell-cell communication· 1 Research Focus:differential expression· 1 Research Focus:gene regulatory network inference· 1 Research Focus:host-pathogen & immune response· 1

Frequent Co-Authors

Christian M. SchürchiD· 2 shared Aleksandra MarkiewicziD· 1 shared Alexander RochwargeriD· 1 shared Antonio VogelsbergiD· 1 shared Armin C. BrauniD· 1 shared Beatrix CucuruziD· 1 shared Christian WernoiD· 1 shared Christoph A. KleiniD· 1 shared

Activity by Year

2025-2026 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 37 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersImmunology

Christian M. SchürchORCID

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

ImmunologybioRxivPreprintJun 10, 2026

High immune receptor clonality in melanoma-draining lymph nodes associates with immune dysfunction and poor survival

Vincent P. Walter, Johanna Herold, Sophia Aurelie Feuchter…·Lukas Flatz

The paper examines immune receptor clonality in melanoma-draining lymph nodes and finds that extreme high clonality is linked to immune dysfunction and poor survival.

DOI 10.64898/2026.06.09.729531

humanbulk RNA-seq

𝕏 PostBluesky

Cancer BiologyNature CancerPeer-reviewedMay 16, 2025

Metastasis founder cells activate immunosuppression early in human melanoma metastatic colonization

Severin Guetter, Courtney König, Huiqin Koerkel-Qu…·Melanie Werner‐Klein

This study identifies MCSP+ melanoma cells as early metastasis founder cells in lymph nodes and shows they activate immunosuppression to evade CD8 T cell attack.

18 citationstop 2%

humanbulk RNA-seq

𝕏 PostBluesky